Objective:
To outline the evolving role of optometrists in managing retinal conditions, particularly in the context of anti-VEGF therapy.
Approach:
- Presentation Overview: Dr. Roya Attar discussed the evolving role of optometrists in retinal care, emphasizing their transition from referral gatekeepers to active partners in longitudinal patient management during her presentation at the American Academy of Optometry meeting.
Key Findings:
- 90% of nAMD patients maintain vision with anti-VEGF treatment; 30-40% experience improvement.
- 40-60% of DME patients see vision improvement; 30-40% achieve complete resolution.
- 50-70% of RVO patients improve, with edema resolution in 60-80%.
- OCT, BCVA, and functional measures are essential for monitoring.
- Persistent IRF correlates with poorer visual outcomes compared to SRF.
Interpretation:
Assessment of retinal conditions should be longitudinal, considering both anatomic and functional responses.
Limitations:
- Variability in treatment response due to genetic factors and disease chronicity.
- Fluctuations in CST and VA may not always indicate recurrence.
Conclusion:
Optometrists should remain actively involved in patient care post-referral, focusing on monitoring treatment responses and maintaining communication with retina specialists.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.